AVITA Medical, Inc. (RCEL)

NASDAQ: RCEL · Real-Time Price · USD
3.960
-0.160 (-3.88%)
At close: Oct 22, 2025, 4:00 PM EDT
3.870
-0.090 (-2.27%)
After-hours: Oct 22, 2025, 6:54 PM EDT
-3.88%
Market Cap120.75M
Revenue (ttm)74.88M
Net Income (ttm)-51.57M
Shares Out 30.49M
EPS (ttm)-1.97
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume214,877
Open4.060
Previous Close4.120
Day's Range3.880 - 4.195
52-Week Range3.600 - 14.160
Beta1.64
AnalystsBuy
Price Target11.80 (+197.98%)
Earnings DateNov 6, 2025

About RCEL

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting devi... [Read more]

Sector Healthcare
CEO Cary Vance
Employees 260
Stock Exchange NASDAQ
Ticker Symbol RCEL
Full Company Profile

Financial Performance

In 2024, AVITA Medical's revenue was $64.25 million, an increase of 28.14% compared to the previous year's $50.14 million. Losses were -$61.85 million, 74.8% more than in 2023.

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for RCEL stock is "Buy." The 12-month stock price target is $11.8, which is an increase of 197.98% from the latest price.

Price Target
$11.8
(197.98% upside)
Analyst Consensus: Buy
Stock Forecasts

News

AVITA Medical Announces CEO Transition

VALENCIA, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical”, or the “Company”), a leading therapeutic acute wound care company, today announced th...

6 days ago - GlobeNewsWire

AVITA MEDICAL INVESTIGATION: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Avita (RCEL) To Contact Him Directly To Discuss Their Options If you purchased or acquired ...

6 days ago - GlobeNewsWire

AVITA REMINDER: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders

Avita revealed a six-month backlog of unpaid Recell claims due to CMS pricing delays, hurting demand and driving shares down 21% to $4.25 on August 8, 2025

13 days ago - GlobeNewsWire

CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds

Hospitals may receive up to $4,875 in added reimbursement when using RECELL to treat non-burn full-thickness acute wounds resulting from trauma or surgery Effective October 1, the add-on payment eases...

21 days ago - GlobeNewsWire

AVITA Medical: Reimbursement Reset And Breakeven Path By 2026

AVITA Medical is building a full-thickness wound workflow. They have the RECELL/RECELL GO, Cohealyx, and PermeaDerm. As a whole, this gives them a holistic platform solution for better clinical integr...

4 weeks ago - Seeking Alpha

RCEL Investors Have Opportunity to Join AVITA Medical, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)---- $RCEL--RCEL Investors Have Opportunity to Join AVITA Medical, Inc. Fraud Investigation with the Schall Law Firm.

5 weeks ago - Business Wire

AVITA Medical, Inc. Investors: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses

6 weeks ago - GlobeNewsWire

AVITA Medical, Inc. (RCEL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

AVITA Medical, Inc. (NASDAQ:RCEL) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 4:05 PM EDT Company Participants James Corbett - CEO, President & Executive Director Presen...

6 weeks ago - Seeking Alpha

AVITA Medical Announces September Investor Conference Participation

VALENCIA, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced th...

2 months ago - GlobeNewsWire

AVITA Medical Successfully Completes Australian Equity Raise

Private placement of approximately 17.2 million new CHESS Depositary Interests (“New CDIs”) quoted on the Australian Securities Exchange (ASX) Issue price of A$1.32 per New CDI, raising approximately ...

2 months ago - GlobeNewsWire

AVITA Medical to Host Investor Webinar Briefing

VALENCIA, Calif., Aug. 10, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholde...

2 months ago - GlobeNewsWire

AVITA Medical, Inc. (RCEL) Q2 2025 Earnings Call Transcript

AVITA Medical, Inc. (NASDAQ:RCEL) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Ben Atkins - Corporate Participant David O'Toole - Chief Financial Officer James M. C...

2 months ago - Seeking Alpha

AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation

VALENCIA, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today reported fin...

2 months ago - GlobeNewsWire

AVITA Medical to Announce Second Quarter 2025 Financial Results

VALENCIA, Calif. and MELBOURNE, Australia, July 28, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solu...

3 months ago - GlobeNewsWire

AVITA Medical's RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards

VALENCIA, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering a portfolio of transformative solutions, tod...

5 months ago - GlobeNewsWire

AVITA Medical, Inc. (RCEL) Q1 2025 Earnings Call Transcript

AVITA Medical, Inc. (NASDAQ:RCEL) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Jessica Ekeberg - Director, Investor Relations Jim Corbett - Chief Executive Officer Dav...

5 months ago - Seeking Alpha

AVITA Medical Reports First Quarter 2025 Financial Results

VALENCIA, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today reported fina...

5 months ago - GlobeNewsWire

AVITA Medical to Announce First Quarter 2025 Financial Results

VALENCIA, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound company delivering transformative solutions, today announced that i...

6 months ago - GlobeNewsWire

AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025

VALENCIA, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering a portfolio of transformative solutions, to...

7 months ago - GlobeNewsWire

AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity

VALENCIA, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced t...

7 months ago - GlobeNewsWire

AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific

AVITA Medical announces new manufacturing agreement and amended distribution agreement with Stedical Scientific to further commercialization of PermeaDerm.

7 months ago - GlobeNewsWire

AVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care Conference

AVITA Medical announced that Jim Corbett, CEO, will present at TD Cowen's 45th Annual Health Care Conference on March 4, 2025, at 11:50 a.m. Eastern Time.

8 months ago - GlobeNewsWire

After Sales Rebound In January, AVITA Is Set Up For A Monster Year

After Sales Rebound In January, AVITA Is Set Up For A Monster Year

8 months ago - Seeking Alpha

AVITA Medical, Inc. (RCEL) Q4 2024 Earnings Call Transcript

AVITA Medical, Inc. (NASDAQ:RCEL) Q4 2024 Earnings Conference Call February 13, 2025 4:30 PM ET Company Participants Jessica Ekeberg - Director of Investor Relations Jim Corbett - Chief Executive Off...

8 months ago - Seeking Alpha

AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results

VALENCIA, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today reported fin...

8 months ago - GlobeNewsWire